|
| ID | Sample size (T/C) | Mean age (years) (T/C) | Diagnostic standards | Type of ulcer (D/G/C) (T/C) | Intervention | Comparison | Course duration (days) | Outcome | Adverse effects |
|
| Li et al. | 112 | T: 42.62 ± 6.71 | The diagnostic methods and criteria for peptic ulcer disease (2010) | T: 30/26/0 | XCHT | Routine treatment | 60 | Clinical efficacy rate, the clinical efficacy of TCM symptoms | T: 3 |
| (56/56) | C: 42.59 ± 6.56 | C: 32/24/0 | | C: 9 |
|
| Wang | 60 | T: 42.8 ± 3.7 | Guidance principle of clinical study on new drug of traditional Chinese medicine (1993) and criteria of diagnosis therapeutic effect of diseases and syndromes in traditional Chinese medicine (1994) | T: 11/19/0 | XCHT | Routine treatment | 75 | Clinical efficacy rate, recurrence rate | T: 0 |
| (30/30) | C: 42.5 ± 3.4 | C: 10/20/0 | C: 6 |
| Luo | 200 | T: 56.2 ± 3.4 | The practice of internal medicine (unclear) and guidance principle of clinical study on new drug of traditional Chinese medicine (1993) | NR | XCHT | Routine treatment | 28 | Clinical efficacy rate, the clinical efficacy of TCM symptoms | NR |
| (100/100) | C: 53 ± 6.4 |
|
| Yang et al. | 166 | NR | Internal medicine teaching (unclear) and guidance principle of clinical study on new drug of traditional Chinese medicine (1993) | NR | XCHT | Routine treatment | 75 | Clinical efficacy rate | NR |
| (83/83) |
|
| Wang | 100 | T: 42.24 ± 7.31 | Internal medicine (unclear) | T: 33/17/0 | XCHT | Routine treatment | 56 | Clinical efficacy rate, recurrence rate, the clinical efficacy of TCM symptoms | NR |
| (50/50) | C: 41.86 ± 6.93 | C: 18/32/0 |
|
| Zhang | 98 | T: 34.13 ± 2.13 | NR | NR | XCHT + routine treatment | Routine treatment | 28 | Clinical efficacy rate | NR |
| (49/49) | C: 34.78 ± 2.12 | NR |
|
| Zeng | 86 | T: 32 ± 2.5 | NR | NR | XCHT + routine treatment | Routine treatment | 30 | Clinical efficacy rate | NR |
| (43/43) | C: 33 ± 2.3 | NR |
|
| Zheng et al. | 68 | T: 37.52 ± 3.25 | Practice of internal medicine (unclear) | NR | XCHT + routine treatment | Routine treatment | 28 | Clinical efficacy rate | T: 5 |
| (43/43) | C: 37.05 ± 3.12 | NR | C: 4 |
|
| Zhang | 94 | T: 55.35 ± 7.24 | Guidance principle of clinical study on new drug of traditional Chinese medicine (2002) and practice of internal medicine (2010) | T: 19/25/3 | XCHT + routine treatment | Routine treatment | 28 | Clinical efficacy rate | NR |
| (47/47) | C: 53.13 ± 6.68 | C: 25/15/7 |
|
| Liu | 120 | T: 36.5 ± 3.9 | Guidance principle of clinical study on new drug of traditional Chinese medicine (2002) and internal medicine (unclear) | T: 19/30/11 | XCHT + routine treatment | Routine treatment | 75 | Clinical efficacy rate, recurrence rate | T: 3 |
| (60/60) | C: 44.5 ± 2.6 | C: 21/29/10 | C: 10 |
|
| Sun | 100 | T: 32 ± 2.5 | Guidance principle of clinical study on new drug of traditional Chinese medicine (1993) and practice of internal medicine (unclear) | T: 18/22/10 | XCHT + routine treatment | Routine treatment | 30 | Clinical efficacy rate, recurrence rate | NR |
| (50/50) | C: 33 ± 2.4 | C: 19/23/8 |
|
| Su et al. | 62 | T: 56.2 ± 5.4 | Guidance principle of clinical study on new drug of traditional Chinese medicine (2002) and practice of internal medicine (2002) | T: 9/20/2 | XCHT + routine treatment | Routine treatment | 28 | Clinical efficacy rate, the clinical efficacy of TCM symptoms | NR |
| (31/31) | C: 53.4 ± 6.2 | C: 9/20/2 |
|
| Ma | 68 | T: 35.2 | Guidance principle of clinical study on new drug of traditional Chinese medicine (2002) and practice of internal medicine (1997) | T: 12/20/6 | XCHT + routine treatment | Routine treatment | 28 | Clinical efficacy rate, recurrence rate | NR |
| (36/32) | C: 37.3 | C: 11/17/4 |
|
